Bayrakdarian; Malken

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bayrakdarian; Malken.The latest application filed is for "substituted benzimidazoles, their preparation and their use as pharmaceuticals".

Company Profile

13.9.13

Bayrakdarian; Malken - Montreal CA
Bayrakdarian; Malken - Miami FL
Bayrakdarian; Malken - Saint Laurent CA
Bayrakdarian; Malken - Verdun CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted benzimidazoles, their preparation and their use as pharmaceuticals Grant 11,365,186 - Pourashraf , et al. June 21, 2	2022-06-21
Substituted Benzimidazoles, Their Preparation And Their Use As Pharmaceuticals App 20210107893 - POURASHRAF; Mehrnaz ; et al.	2021-04-15
N-substituted bicyclic lactams, their preparation and their use as pharmaceuticals Grant 10,836,742 - Jacquemot , et al. November 17, 2	2020-11-17
Aryl-substituted Dihydroquinolinones, Their Preparation And Their Use As Pharmaceuticals App 20200299262 - JACQUEMOT; Guillaume ; et al.	2020-09-24
Substituted [1,2,4]triazolo[4,3-a]pyridines, Their Preparation And Their Use As Pharmaceuticals App 20200299292 - BAYRAKDARIAN; Malken ; et al.	2020-09-24
Substituted Imidazopyridines, Their Preparation And Their Use As Pharmaceuticals App 20200299291 - POURASHRAF; Mehrnaz ; et al.	2020-09-24
Substituted benzimidazoles, their preparation and their use as pharmaceuticals Grant 10,703,740 - Pourashraf , et al.	2020-07-07
N-substituted Bicyclic Lactams, Their Preparation And Their Use As Pharmaceuticals App 20200024253 - JACQUEMOT; Guillaume ; et al.	2020-01-23
Substituted [1,2,4]triazolo[4,3-A]pyridines, their preparation and their use as pharmaceuticals Grant 10,519,151 - Bayrakdarian , et al. Dec	2019-12-31
Substituted imidazo[1,2-a]pyridines as bromodomain inhibitors Grant 10,501,459 - Pourashraf , et al. Dec	2019-12-10
Aryl-substituted dihydroquinolinones, their preparation and their use as pharmaceuticals Grant 10,501,438 - Jacquemot , et al. Dec	2019-12-10
Rac inhibitors Grant 10,472,352 - Lippman , et al. Nov	2019-11-12
Substituted [1,2,4]triazolo[4,3-a]pyridines, Their Preparation And Their Use As Pharmaceuticals App 20190031657 - BAYRAKDARIAN; Malken ; et al.	2019-01-31
Rac Inhibitors App 20190031647 - LIPPMAN; Marc ; et al.	2019-01-31
Substituted Imidazopyridines, Their Preparation And Their Use As Pharmaceuticals App 20180312504 - POURASHRAF; Mehrnaz ; et al.	2018-11-01
Substituted Benzimidazoles, Their Preparation And Their Use As Pharmaceuticals App 20180237417 - POURASHRAF; Mehrnaz ; et al.	2018-08-23
Aryl-substituted Dihydroquinolinones, Their Preparation And Their Use As Pharmaceuticals App 20180230130 - JACQUEMOT; Guillaume ; et al.	2018-08-16
Therapeutic Compounds 570 App 20090099195 - Bayrakdarian; Malken ; et al.	2009-04-16
Pyridin-2-one compounds useful as inhibitors of thrombin App 20070161643 - Bayrakdarian; Malken ; et al.	2007-07-12
Inhibitors of neuraminidases Grant 6,831,096 - Maring , et al. December 14, 2	2004-12-14
Inhibitors of neuraminidases App 20040097471 - Maring, Clarence J. ; et al.	2004-05-20
Inhibitors of neuraminidases Grant 6,455,571 - Maring , et al. September 24, 2	2002-09-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.